Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ecf7b4c1766eed71010670e4da94a5b3 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C45-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C213-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-133 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C217-12 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C217-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-133 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C213-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-06 |
filingDate |
2016-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45cc01649792ecd38729c4e36974f554 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5717583614e955b92d6c9d16f7af9c53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f70cb332baa919344e02c0a9532981d |
publicationDate |
2017-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-106692136-A |
titleOfInvention |
Application of the composition of Harrisotone A derivatives in anti-acute gout medicine |
abstract |
The invention discloses the application of the composition of Harrisotone A derivatives in anti-acute gout medicine, that is, O-(tetrahydropyrrolyl) ethyl derivatives and O-(dihydroxyethylamino) ethyl derivatives of Harrisotone A The application of the composition of the compound in the anti-acute gout drug, the invention relates to the fields of organic synthesis and medicinal chemistry, in particular to the composition, preparation method and application of the Harrisotone A derivative in the preparation of the anti-acute gout drug. The invention discloses a composition of Harrisotone A derivatives and a preparation method thereof. Pharmacological experiments show that the Harrisotone A derivative composition of the present invention has anti-acute gout effect, and has the value of developing anti-acute gout drugs. |
priorityDate |
2016-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |